Auteur: Malfertheiner

Pancreatic cancer is the fourth leading cause of cancer in many countries. This aggressive malignancy must thus be regarded as a common disease, but one that is extremely difficult to treat. Consider …

Diese zweite, vollstandig uberarbeitete Auflage tragt dem seit der Erstauflage 1996 gewonnenen umfangreichen neuen Wissen Rechnung. Von einem Autorenteam verfasst, das uber eigene langjahrige Erfahru …

With the dramatic increase of the aging population, the study and care of gastrointestinal disorders in the elderly have become priority topics for both clinicians and researchers. The geriatric appr …

Clearly structured text, presented with the corresponding illustrations on a two-page spread Compiled by a team of authors with many years’ experience in the field of diseases of the pancreas, this b …

The overall prognosis for patients with gastric cancer remains poor as tumors are often diagnosed at an advanced stage, despite new developments and technical advances in endoscopic diagnosis and the …

The discovery of proton pump inhibitors (PPIs) and their development over the years has dramatically changed the management of acid-related diseases. Today, the therapeutic domain of PPIs ranges from …